Dramatic rise in chemo spending Oncology Update Just six medicines made up 58% of all chemotherapy costs in 2011: new medications rituximab, imatinib, bevacizumab and trastuzumab, and the older, generic medications docetaxel and paclitaxel. Dr Vitry said it "very surprising" to discover that such a ... |
